Melissa Vaanholt finished her bachelor in Psychobiology in 2014 at the University of Amsterdam. In 2016 she completed the master Health Sciences with the track Health Technology Assessment & Innovation (HTAI). Her master thesis was titled "Are Component Endpoints Equal? Use of Best-Worst Scaling to Assess Patients’ Perceptions Regarding the Use of Composite Endpoints in Clinical Trials.” Melissa presented her thesis research at the ISPOR 19th Annual European Congress in Vienna (Austria) in October of that year (podium presentation). After graduation, Melissa started working as a junior researcher at the department of Health Technology and Services Research at the University of Twente.
Health care decision makers and the public have expressed a strong desire for the patient to participate in decision making on the policy and clinical level. In the last two decades many instruments are designed for including patient preferences in health technology assessments (HTA). But there are still some problems with particular areas in HTA regarding patient preferences. Melissa’s research focuses mainly on the integration of patient perspectives in the evaluation of health care innovations and services by using preference methods, mainly discrete choice experiments, best-worst scaling and multi-criteria decision analysis.
Master of Science in Health Sciences, University of Twente
Premaster of Science in Health Sciences, University of Twente
Bachelor of Science in Psychobiology, University of Amsterdam
October 2016 - present
Junior Researcher, Health Technology and Services Research, University of Twente
February 2016 – Sept 2016
Research intern, Thorax Centre Twente, Medisch Spectrum Twente, Enschede, the Netherlands.
February 2015 – Sept 2016
Student Assistant, University of Twente
November 2014 – February 2015
Research intern, Brain & Cognition, University of Amsterdam, the Netherlands
Member of professional societies
International Society for Pharmacoeconomics and Outcomes Research (ISPOR
Melissa C.W. Vaanholt, MSc; Clemens von Birgelen, MD, PhD; Marlies M. Kok, MD; Marieke G.M. Weernink, MSc; Janine A. van Til, PhD.(2016). Are Component Endpoints Equal? Use of Best-worst Scaling to Assess Patients’ Perceptions Regarding the Use of Composite Endpoints in Clinical Trials. In: ISPOR. Vienna.